FMP
Medical Properties Trust, Inc.
MPW
NYSE
Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023. Since the end of the third quarter, the Company has sold four facilities and now owns approximately 43,000 licensed beds in nine countries across three continents. MPT's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
5.87 USD
0.05 (0.852%)
Operating Data
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Revenue
862.13M
1.66B
3.06B
2.82B
3.48B
5.15B
7.63B
11.3B
16.74B
24.79B
Revenue %
-
92.89
83.89
-7.86
23.47
48.1
48.1
48.1
48.1
Ebitda
-353.67M
1.14B
2.23B
1.94B
2.41B
2.46B
3.64B
5.39B
7.98B
11.82B
Ebitda %
-41.02
68.55
72.86
68.8
69.26
47.69
47.69
47.69
47.69
Ebit
-717.44M
793.08M
1.76B
1.22B
1.44B
1.1B
1.63B
2.41B
3.56B
5.28B
Ebit %
-83.22
47.69
57.53
43.22
41.26
21.3
21.3
21.3
21.3
Depreciation
363.78M
346.97M
468.77M
720.63M
974.3M
1.36B
2.01B
2.98B
4.42B
6.54B
Depreciation %
42.2
20.86
15.33
25.58
28.01
26.39
26.39
26.39
26.39
Balance Sheet
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Total Cash
57.92M
48.13M
505.18M
52.66M
23.03M
295.36M
437.42M
647.81M
959.4M
1.42B
Total Cash %
6.72
2.89
16.52
1.87
0.66
5.73
5.73
5.73
5.73
Receivables
137.13M
241.42M
453.82M
472.95M
654.73M
833.32M
1.23B
1.83B
2.71B
4.01B
Receivables %
15.91
14.52
14.84
16.79
18.82
16.17
16.17
16.17
16.17
Inventories
10.58M
12.19M
15.18M
41.81M
38.47M
52M
77.02M
114.06M
168.92M
250.16M
Inventories %
1.23
0.73
0.5
1.48
1.11
1.01
1.01
1.01
1.01
Payable
13.98M
26.26M
58.85M
68.19M
147.14M
121.33M
179.69M
266.11M
394.1M
583.66M
Payable %
1.62
1.58
1.92
2.42
4.23
2.35
2.35
2.35
2.35
Cap Ex
-780.46M
-733.48M
-1.08B
-1.55B
-1.97B
-2.9B
-4.3B
-6.36B
-9.43B
-13.96B
Cap Ex %
-90.53
-44.11
-35.45
-55
-56.54
-56.32
-56.32
-56.32
-56.32
Weighted Average Cost Of Capital
Price
48.62
Beta
Diluted Shares Outstanding
124.08M
Costof Debt
8.12
Tax Rate
After Tax Cost Of Debt
5.69
Risk Free Rate
Market Risk Premium
Cost Of Equity
Total Debt
2.11B
Total Equity
6.03B
Total Capital
8.15B
Debt Weighting
25.96
Equity Weighting
74.04
Wacc
15.81
Build Up Free Cash Flow
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Revenue
862.13M
1.66B
3.06B
2.82B
3.48B
5.15B
7.63B
11.3B
16.74B
24.79B
Ebitda
-353.67M
1.14B
2.23B
1.94B
2.41B
2.46B
3.64B
5.39B
7.98B
11.82B
Ebit
-717.44M
793.08M
1.76B
1.22B
1.44B
1.1B
1.63B
2.41B
3.56B
5.28B
Tax Rate
29.94
29.94
29.94
29.94
29.94
29.94
29.94
29.94
29.94
29.94
Ebiat
-662.84M
648.53M
1.27B
939.85M
1.01B
863.39M
1.28B
1.89B
2.8B
4.15B
Depreciation
363.78M
346.97M
468.77M
720.63M
974.3M
1.36B
2.01B
2.98B
4.42B
6.54B
Receivables
137.13M
241.42M
453.82M
472.95M
654.73M
833.32M
1.23B
1.83B
2.71B
4.01B
Inventories
10.58M
12.19M
15.18M
41.81M
38.47M
52M
77.02M
114.06M
168.92M
250.16M
Payable
13.98M
26.26M
58.85M
68.19M
147.14M
121.33M
179.69M
266.11M
394.1M
583.66M
Cap Ex
-780.46M
-733.48M
-1.08B
-1.55B
-1.97B
-2.9B
-4.3B
-6.36B
-9.43B
-13.96B
Ufcf
-1.21B
168.41M
469.2M
74.25M
-86.43M
-896.61M
-1.37B
-2.03B
-3.01B
-4.46B
Wacc
15.81
15.81
15.81
15.81
15.81
Pv Ufcf
-774.21M
-1.02B
-1.31B
-1.67B
-2.14B
Sum Pv Ufcf
-6.92B
Terminal Value
Growth In Perpetuity Method
Long Term Growth Rate
Wacc
15.81
Free Cash Flow T1
-4.48B
Terminal Value
-29.27B
Present Terminal Value
-14.05B
Intrinsic Value
Enterprise Value
-20.97B
Net Debt
2.09B
Equity Value
-23.06B
Diluted Shares Outstanding
124.08M
Equity Value Per Share
-185.86
Projected DCF
-185.86 1.262%
